Usana Health Sciences (USNA) Cash from Investing Activities (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Cash from Investing Activities data on file, last reported at -$2.6 million in Q2 2026.

• Cash from Investing Activities for Q2 2026 came in at -$2.6 million, up 32.98% year-over-year; the trailing twelve-month figure through Apr 2026 was -$8.8 million (up 95.84% YoY), and the FY2026 annual result was -$10.1 million, up 95.25% from the prior year.
• Cash from Investing Activities declined to -$2.6 million in Q2 2026 per USNA's latest filing, from $1.1 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $1.1 million in Q1 2026 and troughed at -$205.1 million in Q4 2024.
• A 5-year average of -$14.0 million and a median of -$3.2 million in 2022 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities soared 104.81% in 2023, then plunged 2701.67% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at -$3.3 million in 2022, then slumped by 123.1% to -$7.3 million in 2023, then sank by 2701.67% to -$205.1 million in 2024, then surged by 98.44% to -$3.2 million in 2025, then gained by 18.79% to -$2.6 million in 2026.
• Business Quant data shows USNA's Cash from Investing Activities at -$2.6 million in Q2 2026, $1.1 million in Q1 2026, and -$3.2 million in Q3 2025.